What this study is
This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.
What's being tested
- Interview
Intervention · OTHER
Complete interview
- Quality-of-Life Assessment
Intervention · OTHER
Complete quality of life assessment
- Questionnaire Administration
Intervention · OTHER
Complete questionnaires
Study details
- Official title
- Measuring the Symptom Distress of Cancer Patients: Development of a New Assessment System
- Sponsor
- M.D. Anderson Cancer Center
- Conditions
- Caregiver · Health Care Provider · Malignant Neoplasm · Physician
- Enrolling
- 6,500 people
- Starts
- 1999-04-13
- Est. completion
- 2031-04-30
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- NORMAL SAMPLES: Community dwelling adults 18 years of age or older
- PATIENT SAMPLES: Inpatients and outpatients 18 years of age or older, being followed at UT MD Anderson
- EXPERT PANEL PROFESSIONAL PARTICIPANTS: Physician or other healthcare provider with at least 5 years of experience caring for patients with the disease and/or treatment of interest, at least one publication in the last 5 years dealing with the disease and/or treatment of interest (physician only), ability to speak and read English, consent to participate
- EXPERT PANEL FAMILY CAREGIVERS PARTICIPANTS: Identification as a family caregiver by patient enrolled as expert panel participant with the disease and/or treatment of interest, 18 years of age or older, ability to speak and read English, consent to participate
- EXPERT PANEL PATIENT PARTICIPANTS: Patient with identified family caregiver participating on Expert Panel, willingness to receive packet for expert panel participation
You can't join if
- EXPERT PANEL PATIENT PARTICIPANTS: Patient with identified family caregiver participating on expert panel, willingness to receive packet for expert panel participation
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openM D Anderson Cancer Center
Houston, Texas, United States
- Xin Shelley Wang · Contact713-745-3504
- Xin Shelley Wang · Principal investigator
Recruiting
Study team
Sponsor
M.D. Anderson Cancer Center
Study ID BS99-094
Principal investigator
Xin Shelley Wang
M.D. Anderson Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.